A.D. Rao

Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack

Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

The importance of Pharmacovigilance for the drug safety: Focus on cardiovascular profile of incretin-based therapy

Effect of metformin on cardiovascular events and mortality: a meta‐analysis of randomized clinical trials

The mechanisms of action of metformin

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus

A structure-based computational workflow to predict liability and binding modes of small molecules to hERG

Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies

Type 2 diabetes

Differential effects of metformin on age related comorbidities in older men with type 2 diabetes

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Type 2 diabetes mellitus

Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty

Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis

Mortality risk among sulfonylureas: a systematic review and network meta-analysis

Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes

2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial

Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy

Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Pathophysiologic Approach to Therapy in Patients With Newly Diagnosed Type 2 Diabetes

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Diabetic Cardiomyopathy

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes

Cardiovascular safety of sulphonylureas: over 40 years of continuous controversy without an answer

Baseline characteristics of the patient population in the Saxagliptin Assessment of Vascular Outcomes Recorded in patients with diabetes mellitus (SAVOR)‐TIMI 53 trial

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Mineralocorticoid Receptor and Cardiovascular Disease

Effects of Metformin Versus Glipizide on Cardiovascular Outcomes in Patients With Type 2 Diabetes and Coronary Artery Disease

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Mineralocorticoid Receptor Blockade Improves Coronary Microvascular Function in Individuals With Type 2 Diabetes

Is the Combination of Sulfonylureas and Metformin Associated With an Increased Risk of Cardiovascular Disease or All-Cause Mortality?